Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the ...

focusing on the use of Novo Nordisk's GLP-1 agonist Saxenda (liraglutide) and deemed to be effectively large-scale, covert promotion of the weight-loss drug. The ABPI code was updated in 2023 with ...

Sanofi-Synthélabo is known for creating meningitis treatment, Menactra, diabetes treatment Lantus, colorectal cancer drug Eloxatin, and lung, prostate and breast cancer drug Taxorete. While this ...